FDAIdeasThe FDA’s Decision to Pause J&J Could Help Defeat Covid-19By Zoë McLarenBusinessThis AI Could Help Wipe Out Colon CancerBy Sara HarrisonScienceA Shot Nears Approval, Experts Study Transmission, and MoreBy Eve SneiderIdeasThe AstraZeneca Covid Vaccine Data Isn't Up to SnuffBy Hilda BastianScienceWe’ll Need More Than One Vaccine to Beat the PandemicBy Adam RogersIdeasMore Safety Data Would Be Nice, But We Need a Vaccine NowBy Walid GelladThe Big StoryPrevagen Made Millions—as the FDA Questioned Its SafetyBy Chiara EisnerIdeasTrump’s ‘Miracle Cure’ for Covid Is a Logistical NightmareBy Walid GelladIdeasLet’s Get Real About the President’s Antibody TreatmentBy Hilda BastianScienceThe 943-Dimensional Chess of a Trustworthy Covid-19 VaccineBy Adam RogersIdeasDon't Yell About a Rushed Vaccine—Just Plan for ItBy Walid GelladIdeasNo, Public Trust in Scientific Institutions Has Not ErodedBy Daniel EngberIdeasThe FDA's Approach to Covid-19 Is a Bloody MessBy Hilda BastianScienceThe End Is Nearer for ‘Forever Chemicals’ in Food WrappersBy Michele Cohen MarillScienceFDA Revokes Hydroxychloroquine's Emergency Use AuthorizationBy Grace HuckinsScienceThe FDA Asks Companies to Stop Selling RanitidineBy Michele Cohen MarillBusinessJewelry. Candles. Hand Sanitizer. Welcome to Coronavirus EtsyBy Arielle PardesCultureRelease the Kratom: Inside America's Hottest New Drug CultureBy Emma Grey EllisScienceThe FDA Announces Two More Antacid Recalls Due to Cancer RiskBy Michele Cohen MarillBusinessJuul, Under Heavy Fire, Pulls Fruit-Flavored Pods From USBy Sara HarrisonScienceDoes the FDA Even Regulate E-Cigs? Actually Kinda NotBy Sara HarrisonBusinessFDA Says Juul Can't Claim to Be Safer Than CigarettesBy Sara HarrisonBusinessAI Algorithms Need FDA-Style Drug TrialsBy Wired OpinionSecurityHackers Made an App That Kills to Prove a PointBy Lily Hay NewmanMore Stories
